A detailed history of Evanson Asset Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Evanson Asset Management, LLC holds 4,075 shares of ABT stock, worth $483,295. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,075
Previous 4,075 -0.0%
Holding current value
$483,295
Previous $423,000 9.69%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 12, 2024

SELL
$100.73 - $112.44 $5,137 - $5,734
-51 Reduced 1.24%
4,075 $423,000
Q3 2023

Oct 19, 2023

BUY
$95.53 - $114.62 $3,916 - $4,699
41 Added 1.0%
4,126 $399,000
Q2 2023

Jul 10, 2023

BUY
$100.78 - $112.29 $1,007 - $1,122
10 Added 0.25%
4,085 $445,000
Q4 2022

Jan 12, 2023

SELL
$95.06 - $111.52 $22,719 - $26,653
-239 Reduced 5.54%
4,075 $0
Q4 2021

Jan 19, 2022

SELL
$115.53 - $141.46 $81,217 - $99,446
-703 Reduced 14.01%
4,314 $607,000
Q3 2021

Oct 13, 2021

BUY
$116.66 - $129.06 $56,930 - $62,981
488 Added 10.78%
5,017 $588,000
Q3 2020

Oct 13, 2020

SELL
$91.64 - $111.29 $9,164 - $11,129
-100 Reduced 2.16%
4,529 $493,000
Q3 2019

Oct 11, 2019

BUY
$81.84 - $88.74 $8,184 - $8,874
100 Added 2.21%
4,629 $387,000
Q2 2019

Jul 11, 2019

SELL
$72.88 - $85.0 $41,395 - $48,280
-568 Reduced 11.14%
4,529 $381,000
Q1 2019

Apr 09, 2019

SELL
$66.22 - $80.06 $66,551 - $80,460
-1,005 Reduced 16.47%
5,097 $407,000
Q4 2018

Jan 17, 2019

BUY
$65.56 - $74.27 $106,141 - $120,243
1,619 Added 36.11%
6,102 $441,000
Q3 2018

Oct 10, 2018

SELL
$60.81 - $73.36 $390,825 - $471,484
-6,427 Reduced 58.91%
4,483 $329,000
Q2 2018

Jul 11, 2018

BUY
$57.57 - $63.54 $287 - $317
5 Added 0.05%
10,910 $665,000
Q1 2018

Apr 05, 2018

BUY
$56.27 - $63.62 $6,245 - $7,061
111 Added 1.03%
10,905 $653,000
Q3 2017

Nov 14, 2017

BUY
$48.06 - $53.64 $518,759 - $578,990
10,794
10,794 $576,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Evanson Asset Management, LLC Portfolio

Follow Evanson Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evanson Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evanson Asset Management, LLC with notifications on news.